Literature DB >> 28777260

Persistence of parenchymal and perivascular T-cells in treatment-refractory anti-N-methyl-D-aspartate receptor encephalitis.

Alexander Filatenkov1, Timothy E Richardson, Elena Daoud, Sarah F Johnson-Welch, Denise M Ramirez, Jose Torrealba, Benjamin Greenberg, Nancy L Monson, Veena Rajaram.   

Abstract

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disease mediated by IgG1 or IgG3 antibodies to the GluN1 subunit of the NMDAR, resulting in downregulation of NMDARs. Early diagnosis, prompt reduction of anti-NMDAR antibodies, and removal of associated ovarian tumors when identified are important drivers of prognosis. Immunohistochemical studies were carried out to evaluate B cell, plasma cell, and T-cell infiltrates in the brain of a 3-year-old patient with anti-NMDAR encephalitis who failed to show improvement after plasma exchange and Rituximab treatment. Complement activation was evaluated by C4d staining. Plasma cells and B-cells were rarely detected in the brain. In contrast, persistent intraparenchymal infiltrates and perivascular CD3+ T cells and evidence of complement activation were detected. Activated microglia and microglial nodules were also detected in the frontal lobes and the basal ganglia. The role of T cells and complement activation should be investigated in patients who do not respond to plasma exchange and Rituximab treatment.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28777260      PMCID: PMC5578877          DOI: 10.1097/WNR.0000000000000851

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  Brain immunohistopathological study in a patient with anti-NMDAR encephalitis.

Authors:  J-P Camdessanché; N Streichenberger; G Cavillon; V Rogemond; G Jousserand; J Honnorat; P Convers; J-C Antoine
Journal:  Eur J Neurol       Date:  2010-08-16       Impact factor: 6.089

2.  The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project.

Authors:  Mary S Gable; Heather Sheriff; Josep Dalmau; Drake H Tilley; Carol A Glaser
Journal:  Clin Infect Dis       Date:  2012-01-26       Impact factor: 9.079

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

Review 4.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

5.  The spectrum of acute encephalitis: causes, management, and predictors of outcome.

Authors:  Tarun D Singh; Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Neurology       Date:  2014-12-24       Impact factor: 9.910

6.  Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin.

Authors:  H Prüss; J Dalmau; L Harms; M Höltje; G Ahnert-Hilger; K Borowski; W Stoecker; K P Wandinger
Journal:  Neurology       Date:  2010-11-09       Impact factor: 9.910

7.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

8.  Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

Authors:  Nuria Gresa-Arribas; Maarten J Titulaer; Abiguei Torrents; Esther Aguilar; Lindsey McCracken; Frank Leypoldt; Amy J Gleichman; Rita Balice-Gordon; Myrna R Rosenfeld; David Lynch; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-12-18       Impact factor: 44.182

9.  N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children.

Authors:  Sukhvir Wright; Yael Hacohen; Leslie Jacobson; Shakti Agrawal; Rajat Gupta; Sunny Philip; Martin Smith; Ming Lim; Evangeline Wassmer; Angela Vincent
Journal:  Arch Dis Child       Date:  2015-01-30       Impact factor: 3.791

10.  Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus) Knut.

Authors:  H Prüss; J Leubner; N K Wenke; G Á Czirják; C A Szentiks; A D Greenwood
Journal:  Sci Rep       Date:  2015-08-27       Impact factor: 4.379

View more
  2 in total

Review 1.  Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?

Authors:  Robb Wesselingh; Helmut Butzkueven; Katherine Buzzard; David Tarlinton; Terence J O'Brien; Mastura Monif
Journal:  Front Immunol       Date:  2019-09-10       Impact factor: 7.561

2.  Concurrent Tuberculous Meningoencephalitis and Anti-NMDAR Encephalitis: A Case Report.

Authors:  Chen Xiaoli; Wang Qun; Li Jing; Yang Huan; Chen Si
Journal:  Front Neurol       Date:  2022-07-07       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.